Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$1.79 - $2.9 $54,589 - $88,441
30,497 New
30,497 $75,000
Q4 2022

Feb 13, 2023

SELL
$3.38 - $4.22 $11,018 - $13,757
-3,260 Reduced 13.31%
21,233 $77,000
Q2 2022

Aug 10, 2022

BUY
$4.41 - $5.69 $108,014 - $139,365
24,493 New
24,493 $130,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Spouting Rock Asset Management, LLC Portfolio

Follow Spouting Rock Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.